Validation of Analytical Methods according to the New FDA Guidance
•Download as PPTX, PDF•
1 like•77 views
Description: FDA has released a new comprehensive guidance for validation of analytical methods. The guidance follows the modern integrated lifecycle approach with related new requirements for using quality-by-design components, risk assessment, design space and continuous improvement. The guidance will significantly change the way how FDA regulated methods will be developed, validated and used. Because of the novelty of some of the concepts the industry has difficulties to understand and implement the guidance. Attendees of this seminar will understand and learn how to implement the new guidance.
Report
Share
Report
Share
Recommended
Jan Kolaczinski-Enfermedades transmitidas por vectores
El 12 de mayo de 2017 celebramos en la Fundación Ramó Areces una jornada con IS Global y Unitaid sobre enfermedades transmitidas por vectores, como la malaria, entre otras.
Qbd
The document discusses Quality by Design (QbD), which is a systematic approach to pharmaceutical development that begins with predefined objectives and emphasizes product and process understanding based on sound science and quality risk management. QbD involves determining critical quality attributes, understanding how raw materials and process parameters affect those attributes, developing a design space and control strategy to manage the product lifecycle. Design of experiments is a key QbD tool that involves screening factors, response surface methodology, formulation evaluation, computer modeling and validation to optimize the process and enable scale up.
Stabicon Corporate Presentation
Stabicon has been ambitiously established in 2010. Professionally managed with 75 scientists from diverse background expertise. Our organization is specialized in managing product quality process, upgrading and introducing advanced technology into products. we are proud to lay a foundation for prosperous future in prevention and cure segment, future medicine & FMCG business.
Vaccines CMC Analytical Solutions Profile
Covance provides analytical solutions and expertise for vaccines throughout the product lifecycle. This includes assay development, validation, stability testing, characterization, and release testing according to regulatory standards. Using Covance's centralized laboratory allows clients to obtain higher quality data more efficiently compared to using multiple providers. Covance has experience supporting over 12 vaccines in the last three years and offers various analytical techniques and BSL-2 and BSL-3 containment.
Oncology Drug Development Solutions
Oncology has become one of the most research-intensive therapeutic areas and the oncology treatment paradigm has recently shifted to a more patient-centric approach. Drug developers now face many challenges in such a competitive environment. Learn more about the end-to-end solutions for overcoming your oncology trial challenges.
presentation
The document discusses the concept of Pharmaceutical Quality by Design (QbD), which is a systematic approach to pharmaceutical development that emphasizes product and process understanding based on sound science and quality risk management. QbD aims to design quality products and manufacturing processes that consistently deliver intended performance, following ICH guidelines Q8 on pharmaceutical development, Q9 on quality risk management, and Q10 on pharmaceutical quality systems. Implementing QbD provides benefits like eliminating batch failures, minimizing deviations, and ensuring consistent product quality.
Quality by design
The document discusses Quality by Design (QbD), which is defined as using a multidisciplinary team to simultaneously conduct conceptual thinking, product design, and production planning. QbD emphasizes understanding how product and process variables impact quality through science and risk management. It involves defining quality targets, critical quality attributes, and linking these to raw materials and processes. Teams should include specialists from different areas. QbD allows for improved quality, reduced costs and time to market through understanding relationships between inputs and outputs early in development. Implementation requires preparation, training, and overcoming challenges like cultural changes and costs.
Sharon Resume Management 14MAY15-1
Seventeen year career in quality assurance and quality control roles in the pharmaceutical industry, with nine years of management experience ensuring compliant product and process development, manufacturing, and testing. Experience includes creating quality guidelines, managing teams, and leading continuous improvement initiatives.
Recommended
Jan Kolaczinski-Enfermedades transmitidas por vectores
El 12 de mayo de 2017 celebramos en la Fundación Ramó Areces una jornada con IS Global y Unitaid sobre enfermedades transmitidas por vectores, como la malaria, entre otras.
Qbd
The document discusses Quality by Design (QbD), which is a systematic approach to pharmaceutical development that begins with predefined objectives and emphasizes product and process understanding based on sound science and quality risk management. QbD involves determining critical quality attributes, understanding how raw materials and process parameters affect those attributes, developing a design space and control strategy to manage the product lifecycle. Design of experiments is a key QbD tool that involves screening factors, response surface methodology, formulation evaluation, computer modeling and validation to optimize the process and enable scale up.
Stabicon Corporate Presentation
Stabicon has been ambitiously established in 2010. Professionally managed with 75 scientists from diverse background expertise. Our organization is specialized in managing product quality process, upgrading and introducing advanced technology into products. we are proud to lay a foundation for prosperous future in prevention and cure segment, future medicine & FMCG business.
Vaccines CMC Analytical Solutions Profile
Covance provides analytical solutions and expertise for vaccines throughout the product lifecycle. This includes assay development, validation, stability testing, characterization, and release testing according to regulatory standards. Using Covance's centralized laboratory allows clients to obtain higher quality data more efficiently compared to using multiple providers. Covance has experience supporting over 12 vaccines in the last three years and offers various analytical techniques and BSL-2 and BSL-3 containment.
Oncology Drug Development Solutions
Oncology has become one of the most research-intensive therapeutic areas and the oncology treatment paradigm has recently shifted to a more patient-centric approach. Drug developers now face many challenges in such a competitive environment. Learn more about the end-to-end solutions for overcoming your oncology trial challenges.
presentation
The document discusses the concept of Pharmaceutical Quality by Design (QbD), which is a systematic approach to pharmaceutical development that emphasizes product and process understanding based on sound science and quality risk management. QbD aims to design quality products and manufacturing processes that consistently deliver intended performance, following ICH guidelines Q8 on pharmaceutical development, Q9 on quality risk management, and Q10 on pharmaceutical quality systems. Implementing QbD provides benefits like eliminating batch failures, minimizing deviations, and ensuring consistent product quality.
Quality by design
The document discusses Quality by Design (QbD), which is defined as using a multidisciplinary team to simultaneously conduct conceptual thinking, product design, and production planning. QbD emphasizes understanding how product and process variables impact quality through science and risk management. It involves defining quality targets, critical quality attributes, and linking these to raw materials and processes. Teams should include specialists from different areas. QbD allows for improved quality, reduced costs and time to market through understanding relationships between inputs and outputs early in development. Implementation requires preparation, training, and overcoming challenges like cultural changes and costs.
Sharon Resume Management 14MAY15-1
Seventeen year career in quality assurance and quality control roles in the pharmaceutical industry, with nine years of management experience ensuring compliant product and process development, manufacturing, and testing. Experience includes creating quality guidelines, managing teams, and leading continuous improvement initiatives.
Quality by design ( QbD)
This presentation provides an overview of Quality by Design (QbD), a systematic approach to pharmaceutical development that begins with predefined product quality objectives. The key aspects of QbD include establishing a Target Product Profile, identifying Critical Quality Attributes, determining material attributes and critical process parameters linked to Critical Quality Attributes, defining a design space, establishing a control strategy, and conducting risk assessments. QbD aims to ensure final drug product quality through understanding manufacturing processes and controls.
NABL ACCREDITATION
A detailed study on NABL Accreditation, its principles and the approaches for a obtaining an accreditation
MD-Manager Nichols_Becky 2016
This document is a resume for Rebecca L. Nichols summarizing her experience and qualifications for managerial positions in pharmaceuticals, nutraceuticals, and related industries. She has over 20 years of experience leading teams and ensuring on-time project delivery through process improvements. Her expertise includes analytical method development and validation, quality control procedures, and facilitating regulatory filings. She has successfully managed laboratories, mergers, and method transfers between facilities.
East Meets West: Creating a Custom Solution in China to Meet Complex Microbio...
Covance was tasked with supporting a global clinical trial of an anti-infective drug in China. Several challenges arose, including an assay vendor that did not meet quality standards and a regulatory change prohibiting sample export. To address these issues, Covance manufactured assay panels in-house and built a microbiology lab in Shanghai within 6 months. The lab passed inspection and allowed the study to be completed on schedule, demonstrating Covance's ability to customize solutions to meet complex global testing requirements.
Seminar on quality by design
This document summarizes key concepts in quality by design (QbD) for pharmaceutical product and process development. It discusses that QbD is a systematic approach that begins with predefined quality targets and uses product and process understanding to establish design space and process controls. The document outlines critical elements of QbD including quality target product profile, critical quality attributes, critical material attributes, critical process parameters, design space, risk assessment, and design of experiments. It provides examples of each element and explains how they guide development and ensure quality.
Quality by design (QbD)
The document discusses Quality by Design (QbD), which is a systematic approach to pharmaceutical development that begins with predefined objectives and emphasizes product and process understanding and control based on sound science and quality risk management. It defines key QbD elements like Quality Target Product Profile, Critical Quality Attributes, Design Space, and Control Strategy. QbD aims to ensure final drug quality and has benefits like increased understanding, efficiency, and patient safety.
Quality control
The document outlines continual quality improvement methods based on 7 quality management principles including customer focus, leadership, employee engagement, and evidence-based decision making. It describes a quality control process involving in-process quality control, final goods quality assurance through sampling and testing, and procedures for approving, segregating, or reworking non-conforming products before dispatch.
Pat process analytical technique
process analytical technique , pharmacy , quality assurance technique , QAT, Pharmaceutical quality, quality control.
RPS Analytical & Product Development Services
RPS provides analytical and product development services to help pharmaceutical, consumer, and device companies keep their development and manufacturing strategies on track. RPS has expert staff and integrates clients into its infrastructure and core development teams. RPS employs a comprehensive development and manufacturing strategy using a quality-by-design approach to identify and mitigate risks. Case studies demonstrate how RPS can help clients achieve efficiency improvements and cost savings of $1-5 million per year.
Process Analytical Technology (PAT)
The document discusses Process Analytical Technology (PAT), which is defined as a system for designing, analyzing, and controlling manufacturing processes through measurements of critical quality attributes during processing. PAT aims to ensure final product quality by building quality into products through enhanced process understanding and control. The key elements of a PAT framework include process understanding, principles and tools like multivariate analysis, process analyzers, process controls, continuous improvement, and risk-based approaches. PAT offers benefits like increased flexibility, reduced costs and improved yields.
Qbd
Qbd is a technique of planing a safeguard for the formulation from the process of starting material to the final product , its main aim is to built the quality in the product not to testing.
Biosimilar CMC Analytical Master Files & Development Solutions
The successful development of a biosimilar presents unique challenges compared to that of an innovator biologic. In particular, one must prove the biosimilar candidate's structural and functional differences do not have a meaningful impact on the clinical safety and efficacy profile already established for the innovator. Comprehensive and rigorous analytical testing to assess biosimilarity is thus the foundation upon which the successful development of a biosimilar begins.
Qualsys GXP presentation
https://quality.eqms.co.uk/blog/good-practice-in-the-pharmaceutical-industry
What is GxP? What is GxP important for the life science industry? How can you use software to comply with GxP
Good Practice in the Life Science industry
Bilal Husien Oct-2016
Bilal Husien has over 15 years of experience in quality control testing at Pfizer, including managing inventory and shipments of reference standards. He has led projects to improve efficiency and reduce costs, including one that saved $335k. Husien conducts biochemical and immunochemical analysis of samples and ensures compliance with regulations. He is proficient in various lab instruments and systems and has authored standard operating procedures and validation reports.
Bhavesh Resume 8Nov16
Bhavesh Patel has over 5 years of experience in quality assurance, quality control, and analytical method development using HPLC. He has a strong background in auditing and ensuring compliance with regulations from agencies like USFDA, WHO, and MHRA. His experience includes preparing SOPs, conducting audits, developing and validating analytical methods, stability testing, and serving as a training coordinator to ensure employees receive necessary GMP and GLP training. He has a M.Pharm in Pharmaceutical Chemistry and skills in statistical tools, instrumentation like HPLC and GC, method development and validation.
Job Description
Julian Vincent is a Principal Scientist who oversees the manufacture of clinical trial supplies and investigational materials for GlaxoSmithKline. His responsibilities include project managing production timelines and quality, liaising with manufacturing sites, developing manufacturing plans, and ensuring compliance with regulations. He represents the department on project teams and technology transfer teams to coordinate supply needs and communicate externally.
Quality by Design and Process Analytical Technology
This document discusses Quality by Design (QbD) and Process Analytical Technology (PAT) as applied to the pharmaceutical industry. It defines key QbD concepts like Quality Target Product Profile, Critical Quality Attributes, Critical Material Attributes, Critical Process Parameters, and design space. It explains how QbD involves systematic development through risk assessment and control strategies to consistently deliver quality products. PAT is described as using real-time measurements and process monitoring to ensure quality and facilitate continuous improvement. The roles of QbD and PAT in drug development and manufacturing are also summarized.
Process analytical technology
an overview of process analytical technology in pharmaceutical industry.framework and understanding what is PAT
CVQC_SP
The document provides a summary of an individual's experience in quality control and analytical roles in the pharmaceutical industry spanning over 11 years. It includes experience managing quality control testing, method development and validation, documentation, audits, and ensuring compliance with regulatory standards. The individual holds an M.Sc. in Chemistry and has worked in quality control laboratories for several major pharmaceutical companies in India and Oman, taking on roles of increasing responsibility including group leader and assistant manager.
Quality by design
The document provides an overview of Quality by Design (QbD), including its key elements and benefits. QbD is defined as a systematic approach to development that emphasizes product and process understanding based on sound science and quality risk management. The main elements discussed are the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), risk assessment, design space, control strategy, and continual improvement. The benefits of QbD include higher assurance of quality, cost savings, reduced compliance issues, and opportunities for innovation and process improvement. Barriers to implementing QbD include challenges relating to culture, business priorities, and gaining experience with the new concepts.
MICROSOFT
Digital transformation can be either a blessing or a curse depending on how companies approach it. It has shifted power to customers by giving them a voice online. While companies see themselves as delivering value, there is often a large gap between that perception and how customers experience it. Technology allows companies to gain insights into customers and personalize interactions to close that gap and build trust through better experiences.
Dubai Study Tour
This document provides an overview of Dubai from a business study tour presentation. It includes basic information about Dubai such as its location, government structure, and climate. It then analyzes Dubai across several factors: politically Dubai has a dynastic government structure with each Emirate having its own institutions; economically Dubai has transitioned away from an oil-based economy to one focused on tourism, real estate, and finance; socially Dubai has a large expatriate population and practices religious tolerance; technologically Dubai has industrial areas, ports, an international airport, and advanced infrastructure; legally crime rates are low and punishments are strict; and environmentally Dubai has a hot desert climate and faces issues from desalination plants
More Related Content
What's hot
Quality by design ( QbD)
This presentation provides an overview of Quality by Design (QbD), a systematic approach to pharmaceutical development that begins with predefined product quality objectives. The key aspects of QbD include establishing a Target Product Profile, identifying Critical Quality Attributes, determining material attributes and critical process parameters linked to Critical Quality Attributes, defining a design space, establishing a control strategy, and conducting risk assessments. QbD aims to ensure final drug product quality through understanding manufacturing processes and controls.
NABL ACCREDITATION
A detailed study on NABL Accreditation, its principles and the approaches for a obtaining an accreditation
MD-Manager Nichols_Becky 2016
This document is a resume for Rebecca L. Nichols summarizing her experience and qualifications for managerial positions in pharmaceuticals, nutraceuticals, and related industries. She has over 20 years of experience leading teams and ensuring on-time project delivery through process improvements. Her expertise includes analytical method development and validation, quality control procedures, and facilitating regulatory filings. She has successfully managed laboratories, mergers, and method transfers between facilities.
East Meets West: Creating a Custom Solution in China to Meet Complex Microbio...
Covance was tasked with supporting a global clinical trial of an anti-infective drug in China. Several challenges arose, including an assay vendor that did not meet quality standards and a regulatory change prohibiting sample export. To address these issues, Covance manufactured assay panels in-house and built a microbiology lab in Shanghai within 6 months. The lab passed inspection and allowed the study to be completed on schedule, demonstrating Covance's ability to customize solutions to meet complex global testing requirements.
Seminar on quality by design
This document summarizes key concepts in quality by design (QbD) for pharmaceutical product and process development. It discusses that QbD is a systematic approach that begins with predefined quality targets and uses product and process understanding to establish design space and process controls. The document outlines critical elements of QbD including quality target product profile, critical quality attributes, critical material attributes, critical process parameters, design space, risk assessment, and design of experiments. It provides examples of each element and explains how they guide development and ensure quality.
Quality by design (QbD)
The document discusses Quality by Design (QbD), which is a systematic approach to pharmaceutical development that begins with predefined objectives and emphasizes product and process understanding and control based on sound science and quality risk management. It defines key QbD elements like Quality Target Product Profile, Critical Quality Attributes, Design Space, and Control Strategy. QbD aims to ensure final drug quality and has benefits like increased understanding, efficiency, and patient safety.
Quality control
The document outlines continual quality improvement methods based on 7 quality management principles including customer focus, leadership, employee engagement, and evidence-based decision making. It describes a quality control process involving in-process quality control, final goods quality assurance through sampling and testing, and procedures for approving, segregating, or reworking non-conforming products before dispatch.
Pat process analytical technique
process analytical technique , pharmacy , quality assurance technique , QAT, Pharmaceutical quality, quality control.
RPS Analytical & Product Development Services
RPS provides analytical and product development services to help pharmaceutical, consumer, and device companies keep their development and manufacturing strategies on track. RPS has expert staff and integrates clients into its infrastructure and core development teams. RPS employs a comprehensive development and manufacturing strategy using a quality-by-design approach to identify and mitigate risks. Case studies demonstrate how RPS can help clients achieve efficiency improvements and cost savings of $1-5 million per year.
Process Analytical Technology (PAT)
The document discusses Process Analytical Technology (PAT), which is defined as a system for designing, analyzing, and controlling manufacturing processes through measurements of critical quality attributes during processing. PAT aims to ensure final product quality by building quality into products through enhanced process understanding and control. The key elements of a PAT framework include process understanding, principles and tools like multivariate analysis, process analyzers, process controls, continuous improvement, and risk-based approaches. PAT offers benefits like increased flexibility, reduced costs and improved yields.
Qbd
Qbd is a technique of planing a safeguard for the formulation from the process of starting material to the final product , its main aim is to built the quality in the product not to testing.
Biosimilar CMC Analytical Master Files & Development Solutions
The successful development of a biosimilar presents unique challenges compared to that of an innovator biologic. In particular, one must prove the biosimilar candidate's structural and functional differences do not have a meaningful impact on the clinical safety and efficacy profile already established for the innovator. Comprehensive and rigorous analytical testing to assess biosimilarity is thus the foundation upon which the successful development of a biosimilar begins.
Qualsys GXP presentation
https://quality.eqms.co.uk/blog/good-practice-in-the-pharmaceutical-industry
What is GxP? What is GxP important for the life science industry? How can you use software to comply with GxP
Good Practice in the Life Science industry
Bilal Husien Oct-2016
Bilal Husien has over 15 years of experience in quality control testing at Pfizer, including managing inventory and shipments of reference standards. He has led projects to improve efficiency and reduce costs, including one that saved $335k. Husien conducts biochemical and immunochemical analysis of samples and ensures compliance with regulations. He is proficient in various lab instruments and systems and has authored standard operating procedures and validation reports.
Bhavesh Resume 8Nov16
Bhavesh Patel has over 5 years of experience in quality assurance, quality control, and analytical method development using HPLC. He has a strong background in auditing and ensuring compliance with regulations from agencies like USFDA, WHO, and MHRA. His experience includes preparing SOPs, conducting audits, developing and validating analytical methods, stability testing, and serving as a training coordinator to ensure employees receive necessary GMP and GLP training. He has a M.Pharm in Pharmaceutical Chemistry and skills in statistical tools, instrumentation like HPLC and GC, method development and validation.
Job Description
Julian Vincent is a Principal Scientist who oversees the manufacture of clinical trial supplies and investigational materials for GlaxoSmithKline. His responsibilities include project managing production timelines and quality, liaising with manufacturing sites, developing manufacturing plans, and ensuring compliance with regulations. He represents the department on project teams and technology transfer teams to coordinate supply needs and communicate externally.
Quality by Design and Process Analytical Technology
This document discusses Quality by Design (QbD) and Process Analytical Technology (PAT) as applied to the pharmaceutical industry. It defines key QbD concepts like Quality Target Product Profile, Critical Quality Attributes, Critical Material Attributes, Critical Process Parameters, and design space. It explains how QbD involves systematic development through risk assessment and control strategies to consistently deliver quality products. PAT is described as using real-time measurements and process monitoring to ensure quality and facilitate continuous improvement. The roles of QbD and PAT in drug development and manufacturing are also summarized.
Process analytical technology
an overview of process analytical technology in pharmaceutical industry.framework and understanding what is PAT
CVQC_SP
The document provides a summary of an individual's experience in quality control and analytical roles in the pharmaceutical industry spanning over 11 years. It includes experience managing quality control testing, method development and validation, documentation, audits, and ensuring compliance with regulatory standards. The individual holds an M.Sc. in Chemistry and has worked in quality control laboratories for several major pharmaceutical companies in India and Oman, taking on roles of increasing responsibility including group leader and assistant manager.
Quality by design
The document provides an overview of Quality by Design (QbD), including its key elements and benefits. QbD is defined as a systematic approach to development that emphasizes product and process understanding based on sound science and quality risk management. The main elements discussed are the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), risk assessment, design space, control strategy, and continual improvement. The benefits of QbD include higher assurance of quality, cost savings, reduced compliance issues, and opportunities for innovation and process improvement. Barriers to implementing QbD include challenges relating to culture, business priorities, and gaining experience with the new concepts.
What's hot (20)
East Meets West: Creating a Custom Solution in China to Meet Complex Microbio...
East Meets West: Creating a Custom Solution in China to Meet Complex Microbio...
Biosimilar CMC Analytical Master Files & Development Solutions
Biosimilar CMC Analytical Master Files & Development Solutions
Quality by Design and Process Analytical Technology
Quality by Design and Process Analytical Technology
Viewers also liked
MICROSOFT
Digital transformation can be either a blessing or a curse depending on how companies approach it. It has shifted power to customers by giving them a voice online. While companies see themselves as delivering value, there is often a large gap between that perception and how customers experience it. Technology allows companies to gain insights into customers and personalize interactions to close that gap and build trust through better experiences.
Dubai Study Tour
This document provides an overview of Dubai from a business study tour presentation. It includes basic information about Dubai such as its location, government structure, and climate. It then analyzes Dubai across several factors: politically Dubai has a dynastic government structure with each Emirate having its own institutions; economically Dubai has transitioned away from an oil-based economy to one focused on tourism, real estate, and finance; socially Dubai has a large expatriate population and practices religious tolerance; technologically Dubai has industrial areas, ports, an international airport, and advanced infrastructure; legally crime rates are low and punishments are strict; and environmentally Dubai has a hot desert climate and faces issues from desalination plants
3Com 000790-01
Launch 3 Telecom sells a 3Com 000790-01 product and provides information on purchasing, shipping, returns, and additional services. Customers can purchase the product by phone, email, or online request form with payment by credit card, purchase order, or government purchase. Orders placed before 3PM ship same day generally with tracking. The product comes with a warranty and return policy. Additional services include repairs, maintenance contracts, de-installation, storage, and third party logistics.
3Com 030-11099-3001
This document provides information about purchasing a 3Com 030-11099-3001 product from Launch 3 Telecom. It describes how to purchase the product via phone, email, or by filling out a request form online. It also provides details about payment methods, same-day shipping and tracking, warranty, and additional services offered by Launch 3 Telecom such as repairs, maintenance contracts, and de-installation of telecom equipment.
Chemical Composition of the Biomass of Saccharomyces cerevisiae - (Meyen ex E...
Brewer's yeast was subjected to analytical studies to determine the chemical composition of its biomass. To this end, traditional methods of analysis were used to determine ribonucleic acid (RNA), mineral elements, amino acids and fatty acids. The results showed that proteins (49.63%), carbohydrates (31.55%), minerals (7.98%), RNA (8.12%) and total lipids (4.64%) predominate in the biomass composition. The amino acid profile of the protein is suitable for human nutrition, exceeding the recommendations from the FAO/WHO/UNU for essential amino acids. It is particularly rich in lysine and could be recommended as protein supplement in cereals. It was also observed that the yeast was an excellent source of some microelements, such as selenium, chromium, nickel and lithium; that it is also a good source of dietary fiber, particularly soluble fibers; and that the content of lipids was low, with a predominance of saturated and mono-unsaturated fatty acids with 10, 16 and 18 carbon atoms.
3Com 00058094
This document provides information about 3Com network cards and details Launch 3 Telecom's services for purchasing, shipping, returning, and supporting 3Com 00058094 network cards. Launch 3 Telecom is a supplier and service provider of telecom hardware that accepts various payment methods for purchasing 3Com 00058094 cards with same-day shipping and return options. They also offer repair, maintenance, installation, and asset recovery services.
The Electrophoretic Profile Myofibrillar Proteins Extracted From Camel Muscle...
Changes in electrophoretic profiles of myofibrillar protein (MFP) in the Longissimus thoracis (LD) of young camels (2 to 4 years), preserved by refrigeration has been treated or not by lactic acid solution 4% or citric acid 1%, were followed during the post-mortem time at the following times: 1, 2, 4, 6, 8, 10, 12, 24 and 48 hours. The cold preservation for 48 hours has not shown any particular distinctions in the protein profiles of this muscle. Changes related to the type of treatment were recorded during the storage time. Proteolysis of the myofibrillar fraction was earlier in this muscle in the case of treatment with one of two solutions of organic acids used, particularly in the case of using lactic acid. Indeed, these changes have affected at the first hour after slaughter the proteolysis of the myofibrillar proteins. Fragments of low molecular weight (42, 36, 33, 26, 23, 18, 16, 14 and 13 kDa) have been identified. The electrophoretic analysis showed that during refrigeration, LD treated with a solution of lactic acid is more sensitive to disruption phenomena and muscle protein proteolysis that lots of this muscle that even in the case of preservation by refrigeration only or by refrigeration
3Com 69-003678-00
This document provides information about purchasing a 3Com 69-003678-00 CMTS Cable-Return Hub from Launch 3 Telecom. It details how to purchase the product via phone, email, or by submitting a request for quote online. It also provides information on payment methods, same-day shipping and order tracking, warranty, and additional services offered by Launch 3 Telecom such as repairs, maintenance contracts, de-installation, and recycling.
Viewers also liked (8)
Chemical Composition of the Biomass of Saccharomyces cerevisiae - (Meyen ex E...
Chemical Composition of the Biomass of Saccharomyces cerevisiae - (Meyen ex E...
The Electrophoretic Profile Myofibrillar Proteins Extracted From Camel Muscle...
The Electrophoretic Profile Myofibrillar Proteins Extracted From Camel Muscle...
Similar to Validation of Analytical Methods according to the New FDA Guidance
Apply quality standards.pdf
This document discusses quality standards and quality management processes for surveying projects. It defines key terms like quality, standards, quality assurance and quality control. It describes the benefits of standards and outlines the Plan-Do-Check-Act model for quality processes. Quality standards help ensure accurate, reliable survey results and monitoring is needed to check that standards and requirements are met. The three main quality management processes are quality planning, quality assurance and quality control.
quality_management_plan_4108_ppt_final.pptx
This document provides a quality management plan template for a project to expand a company's retail operations into physical stores. The template includes sections for an introduction, quality objectives, roles and responsibilities, quality assurance activities, quality control measures, change management, quality improvement, documentation, reasons for using the template, constraints, and references. The quality objectives are to meet customer expectations, deliver a high-quality store aligned with brand standards, minimize defects and rework, and continually improve deliverables. Roles defined include a project manager, quality assurance team, and project team members. Quality assurance activities cover planning, control, and documentation. Quality control measures include inspections, testing, and supplier management.
quality_management_plan_4108 ppt final.pptx
This document provides a quality management plan template for a project to expand a company's retail operations into physical stores. The template includes sections for an introduction, quality objectives, roles and responsibilities, quality assurance activities, quality control measures, change management, quality improvement, documentation, reasons for using the template, constraints, and references. The quality objectives are to meet customer expectations, deliver a high-quality store aligned with brand standards, minimize defects and rework, and continually improve deliverables. Roles defined include a project manager, quality assurance team, and project team members. Quality assurance activities cover planning, control, and documentation. Quality control measures include inspections, testing, and supplier management.
Episode 24 : Project Quality Management
Episode 24 : Project Quality Management
Include the processes required to ensure that the project will satisfy the needs for which it was undertaken
Include all activities of the overall management function that determine the quality policy, objectives and responsibilities and implements them by means such as quality planning, quality assurance, quality control, and quality improvement, within the quality system
Qby d presentation-20jun12ppt
This document discusses moving from a quality by testing approach to a quality by design approach for method validation and transfer. It proposes a three stage lifecycle process for method validation that begins with method design to define objectives and critical controls. Stage two involves method qualification to confirm the method meets its design. Stage three provides for continued method verification to ensure the method remains fit for use. This lifecycle approach focuses on collecting data and knowledge throughout the method's use to consistently deliver quality results. The document advocates applying quality by design principles to stability studies to reduce testing and costs by focusing on attributes likely to change over time.
Quality by design in analytical method developmentpptx
This document summarizes a student presentation on quality by design in analytical method development. It discusses:
1) Why QbD is important for analytical methods to improve understanding, ease of improvement, and relationship to process control.
2) The key differences between traditional and QbD analytical method development, including use of an analytical target profile, design of experiments to understand method variables, and concept of a method lifecycle rather than one-time validation.
3) Tools used in QbD analytical method development like risk assessment, identification of critical quality attributes, method design, and qualification to ensure method performance.
quality by design in pharmaceutical development ICH Q8 guideliness
The document provides an overview of ICH Q8 guidelines for quality by design (QbD) in pharmaceutical development. It discusses key aspects of the QbD framework including defining critical quality attributes and critical process parameters. The guidelines aim to enhance product and process understanding using a science- and risk-based approach. This allows for greater control and consistency in manufacturing. The document also outlines regulatory and industry perspectives, as well as examples of applying QbD and modeling techniques scientifically.
Method validation and Verification .pdf
This document discusses method validation and verification requirements. It defines validation as confirmation that requirements for a specific intended use are fulfilled, and verification as provision of evidence that specified requirements are adequate for intended use. Validation is required for non-standard methods, standard methods used outside their scope, and modifications to standard methods. Validation should demonstrate accuracy, precision, sensitivity, specificity and other method performance characteristics. The extent of validation needed depends on factors like the application and technical possibilities. Laboratories must document validation procedures and results.
Quality by design pptx.pdf
The document provides an overview of Quality by Design (QbD) for a Master's of Pharmacy presentation. It discusses key QbD concepts like the Quality Target Product Profile (QTPP), Critical Quality Attributes (CQAs), Critical Process Parameters (CPPs), risk assessment, design space, and regulatory aspects. It also introduces Six Sigma and its tools/techniques for continuous improvement, including its DMAIC methodology of Define, Measure, Analyze, Improve, and Control phases. The presentation aims to explain how QbD and Six Sigma can help build quality into pharmaceutical products and manufacturing processes through a systematic and science-based approach.
Method development
The document provides details on method development for chromatography. It discusses defining key terms, developing a test method plan, optimizing methods through experimental design techniques like factorial design. The method development process involves studying samples, setting goals, reviewing literature, selecting an approach, optimizing parameters, and finalizing the method. Critical parameters like column length and temperature, flow rate, mobile phase composition are identified for optimization. Formal validation is required once the method is developed.
Quality by design.. ppt for RA (1ST SEM
This document discusses quality by design (QbD) in pharmaceutical development. It begins with introducing QbD as a systematic approach to development that emphasizes product and process understanding based on science and risk management. The key elements of QbD discussed include establishing a quality target product profile, identifying critical quality attributes, conducting risk assessments, defining a design space and control strategy, and enabling continual improvement. A case study demonstrates how QbD improved impurity control for a drug substance. Overall, the document provides an overview of the principles and tools of QbD and its benefits for ensuring quality and facilitating regulatory assessment and flexibility.
PMP-Scope Management area
The document discusses key concepts in project scope management according to the PMBOK Guide. It defines product and project scope, and outlines the main processes involved - plan scope management, collect requirements, define scope, create the work breakdown structure, validate scope, and control scope. For each process, it lists the typical inputs, tools and techniques, and outputs as defined in the PMBOK Guide. It also provides more details on some of the tools and techniques used such as interviews, prototypes, and variance analysis.
Process Validation for Drugs and Biologics
This training course provides an understanding of process validation requirements for pharmaceutical and biologic products. Participants will learn how to establish effective process validation systems and integrate them with other quality systems. They will also learn how to develop validation protocols and reports, as well as monitoring programs, to ensure critical process parameters remain in control. The course reviews validation needs for electronic systems and covers the FDA's process validation lifecycle approach.
PROJECT QUALITY MANAGEMENT for Project.ppt
The document discusses project quality management. It describes the three main processes as plan quality, perform quality assurance, and perform quality control. Plan quality involves identifying quality requirements. Perform quality assurance involves auditing quality requirements and ensuring standards are followed. Perform quality control involves monitoring results, assessing performance, and recommending changes. It provides details on key activities, tools, and outputs for each of the three processes.
Session 12 4th edition PMP
This document discusses project quality management. It defines quality as the degree to which a project fulfills requirements. Quality management includes creating and following policies and procedures to ensure a project meets customer needs. Completing a project with no deviations from requirements is the goal. The document discusses quality planning, assurance, and control processes. It also discusses quality concepts, tools like control charts and benchmarking, and influential quality management thinkers like Deming, Crosby, and Juran.
7.quality management chapter 7
This document discusses various topics relating to software quality management. It defines quality management as ensuring the required level of quality is achieved in a software product by defining quality standards and procedures. It discusses what quality means for software and some challenges in specifying quality requirements. It also covers the scope and key activities of quality management including quality assurance, planning, and control. Quality standards, reviews, and metrics are described as important aspects of quality management.
quality-metrics-1.pdf
The document discusses the FDA's Quality Metrics program, which aims to use quality metrics data submitted voluntarily by manufacturers to enhance regulatory oversight. It provides an overview of the program's objectives, outlines its evolution from an initial to revised draft guidance, and discusses benefits of participation and the FDA's goals for the short and long term development of the program. The overall vision is for a more efficient and flexible pharmaceutical manufacturing sector that reliably produces high-quality drugs requiring minimal regulatory oversight.
Quality of design
QbD is intended to enhance process knowledge and product quality. It is a quality system that builds on past regulatory expectations and sets future expectations. QbD involves identifying critical quality attributes and understanding their impact on product quality through risk assessment and experimentation. The goal is to develop a robust process control strategy supported by scientific understanding and documentation that can evolve as knowledge increases.
REGULATORY AND INDUSTRY VIEWS ON QbD (1).pptx
Quality by Design (QbD) is a regulatory initiative that requires designing and building quality into pharmaceutical products and manufacturing processes. QbD focuses on understanding manufacturing processes and identifying critical quality attributes through risk assessment and control strategies. Regulatory agencies like the FDA and EMA support QbD as it can facilitate more efficient regulatory reviews and manufacturing changes. Industry can benefit from QbD through reduced costs, improved yields and consistency, and timely product launches.
DAY_1 L4 Concepts for implementing a quality management system RevPV.pdf
The document provides guidance on implementing a quality management system using a step-by-step process approach. It outlines identifying processes, writing procedures, training personnel, conducting internal audits and management reviews, and continually improving the system. The key steps are deciding to implement, gaining management commitment, forming an implementation team to plan and design the system, documenting procedures, training staff, piloting the system, conducting an internal audit, and having management review progress and identify improvements.
Similar to Validation of Analytical Methods according to the New FDA Guidance (20)
Quality by design in analytical method developmentpptx
Quality by design in analytical method developmentpptx
quality by design in pharmaceutical development ICH Q8 guideliness
quality by design in pharmaceutical development ICH Q8 guideliness
DAY_1 L4 Concepts for implementing a quality management system RevPV.pdf
DAY_1 L4 Concepts for implementing a quality management system RevPV.pdf
Recently uploaded
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...National Information Standards Organization (NISO)
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.Advanced Java[Extra Concepts, Not Difficult].docx
This is part 2 of my Java Learning Journey. This contains Hashing, ArrayList, LinkedList, Date and Time Classes, Calendar Class and more.
The Diamonds of 2023-2024 in the IGRA collection
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
A Strategic Approach: GenAI in Education
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Types of Herbal Cosmetics its standardization.
Physiology and chemistry of skin and pigmentation, hairs, scalp, lips and nail, Cleansing cream, Lotions, Face powders, Face packs, Lipsticks, Bath products, soaps and baby product,
Preparation and standardization of the following : Tonic, Bleaches, Dentifrices and Mouth washes & Tooth Pastes, Cosmetics for Nails.
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
it describes the bony anatomy including the femoral head , acetabulum, labrum . also discusses the capsule , ligaments . muscle that act on the hip joint and the range of motion are outlined. factors affecting hip joint stability and weight transmission through the joint are summarized.
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit - NGV Pavilion Concept Design
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar KanvariaTop five deadliest dog breeds in America
Thinking of getting a dog? Be aware that breeds like Pit Bulls, Rottweilers, and German Shepherds can be loyal and dangerous. Proper training and socialization are crucial to preventing aggressive behaviors. Ensure safety by understanding their needs and always supervising interactions. Stay safe, and enjoy your furry friends!
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxMohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
How to Add Chatter in the odoo 17 ERP Module
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Let’s explore the intersection of technology and equity in the final session of our DEI series. Discover how AI tools, like ChatGPT, can be used to support and enhance your nonprofit's DEI initiatives. Participants will gain insights into practical AI applications and get tips for leveraging technology to advance their DEI goals.
Assessment and Planning in Educational technology.pptx
In an education system, it is understood that assessment is only for the students, but on the other hand, the Assessment of teachers is also an important aspect of the education system that ensures teachers are providing high-quality instruction to students. The assessment process can be used to provide feedback and support for professional development, to inform decisions about teacher retention or promotion, or to evaluate teacher effectiveness for accountability purposes.
Recently uploaded (20)
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Assessment and Planning in Educational technology.pptx
Assessment and Planning in Educational technology.pptx
Validation of Analytical Methods according to the New FDA Guidance
- 1. GRC Training Solutions Contact Us: Email:david@grcts.com. Tel:+1-248-233-2049 Web:www.grcts.com
- 2. FDA has released a new comprehensive guidance for validation of analytical methods. The guidance follows the modern integrated lifecycle approach with related new requirements for using quality- by-design components, risk assessment, design space and continuous improvement. The guidance will significantly change the way how FDA regulated methods will be developed, validated and used. Because of the novelty of some of the concepts the industry has difficulties to understand and implement the guidance. Attendees of this seminar will understand and learn how to implement the new guidance. Description
- 3. • Key differences to the existing guidance • Scope and content of the guidance • Going through validation parameters, tests, and acceptance criteria • Comparison with ICH Q2 • How to apply the lifecycle management for analytical procedures • When and how to periodic review and revalidate methods • Analytical method comparability studies for alternative methods • Recommendations analytical method transfer studies • Development experiments that should be conducted under GMP conditions • Application of QbD components: design space, multivariate experiments, risk assessment. Topics
- 4. • QC managers • QA managers and personnel • Laboratory managers and supervisors • Analysts • Regulatory affairs • Training departments • Documentation department • Consultants Who will benefit (by Function)
- 5. Ludwig Huber, Ph.D., is the director of Labcompliance and editor of www.labcompliance.com, the global online resource for validation and compliance. He is the author of the books "Validation and Qualification in Analytical Laboratories" and "Validation of Computerized Analytical and Networked Systems". He has given multiple presentations mainly on GLP/GMP, 21 CFR Part 11 and Validation around the world. This included seminars, workshops and presentations for the US FDA, China CFDA, ISPE, PDA, PIC/S and several other industry organizations and national health care agencies. For more information, please visit Dr.Huber’s website www.ludwig-huber.com. Instructor Profile